Nuvectis Pharma Financial Overview
Nuvectis Pharma's market cap is currently $197.49M. The company's EPS TTM is $-0.44; its P/E ratio is -5.87; Nuvectis Pharma is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
